You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 134 No. 11, November 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Problem Solving: Radiology
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Radiology of Head & Neck
 •Diagnosis
 •Drug Therapy
 •Adverse Effects
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Radiology Quiz Case: Diagnosis

Arch Otolaryngol Head Neck Surg. 2008;134(11):1230-1231.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Diagnosis: Osteonecrosis of the jaw: aminobisphosphonate epidemic

Osteonecrosis is the death of a bone or a part of a bone that results as a natural consequence of a wide variety of systemic and local factors that compromise the blood flow within the bone, including hemoglobinopathies, anticardiolipin antibodies, defects of the thrombotic and fibrinolytic systems, fat emboli, alcoholism, systemic lupus erythematosus, and corticosteroid administration.1 It simulates the ischemic condition in the heart but has also been called the coronary disease of the mandible. A few years ago, previous head and neck radiotherapy was the factor most commonly associated with mandibular osteonecrosis.

Bisphosphonates are a group of drugs that were discovered in the late 1960s for the treatment of diseases with undesirably high bone resorption rates, such as Paget disease and tumor-induced hypercalcemia, as well as for the treatment of bone metastases, eg, in cases of multiple myeloma and breast or prostate cancer. In the last several years, oral . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Radiology Quiz Case
Luis Junquera, Lorena Gallego, and Pedro Villarreal
Arch Otolaryngol Head Neck Surg. 2008;134(11):1229.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.